Published: 27 Jun 2023 | Last Updated: 10 Jul 2023 15:31:04

New research from the Royal Veterinary College has shed light on the frequency and risk factors associated with osteosarcoma bone cancer in dogs in the UK

New research from the Royal Veterinary College (RVC) has revealed the frequency and risk factors for osteosarcoma across dog breeds in the UK. Osteosarcoma, a cancerous bone tumour, was found to be much more common in giant dogs, including the Scottish Deerhound (3.28% of all dogs affected each year), Leonberger (1.48%), Great Dane (0.87%) and Rottweiler (0.84%).

This is the largest study ever undertaken on osteosarcoma in dogs using veterinary clinical records. The results will help owners, veterinarians, breeders and researchers to understand the risks of this important bone cancer in their breed and to update their strategies to support healthier dogs.

Osteosarcoma is a serious malignant bone tumour. Dogs with osteosarcoma often show signs of lameness with bony or soft tissue swelling which can be severely painful. Canine and human osteosarcoma present clinically with similar characteristics, clinical timelines and tumour biology. Therefore, studies on canine osteosarcoma can also be highly valuable in informing studies and knowledge of the disease in humans.

This study found that giant dog breeds had a significant risk of osteosarcoma compared to crossbreed dogs. Scottish Deerhounds were 118 times more likely to develop osteosarcoma than crossbreed dogs, Leonbergers were 56 times more likely, Great Danes 34 times and Rottweilers 27 times.

Fortunately, the study also identified several breeds with a relatively low risk of osteosarcoma in comparison to crossbreeds, including English Cocker Spaniels (x 0.18 times), Shih Tzus (x 0.12 times) and Jack Russell Terriers (x 0.05 times). The differences between these high-risk and low-risk breeds help us to understand that selecting dogs towards having a giant body size is one of the key drivers for osteosarcoma bone cancer in dogs.

The study was led by the RVC’s VetCompass programme and investigated the frequency of osteosarcoma and associated risk factors in different dog breeds in the UK. The study, using veterinary clinical records, looked at a sample of 905,552 UK dogs, consisting of all breeds under first opinion veterinary care during 2016.

The research found 331 osteosarcoma cases in the population, giving a one-year frequency of 0.037%, showing that osteosarcoma bone cancer is not common in dogs generally. Increased bodyweight and aging were associated with increasing risk of osteosarcoma; the average age at diagnosis was 9.64 years and the average adult bodyweight of affected dogs was 33.04kg, compared with an average of just 13.95kg in dogs without osteosarcoma.

Additional findings include:

• Skull shape influenced osteosarcoma risk. Breeds with long faces (dolichocephalic skulls) had increased risk (x 2.72) of osteosarcoma while breeds with flat faces (brachycephalic skulls) had reduced risk (x 0.50) compared with breeds with medium-length faces (mesocephalic skulls).
• Breeds with a genetic mutation towards shortened legs (chondrodystropy) such as Dachshund and Corgi had reduced risk (x 0.10) of osteosarcoma compared with breeds without this chondrodystrophy mutation (e.g. Labrador Retriever, German Shepherd).
• Insured dogs were 1.71 times more likely to be formally diagnosed with osteosarcoma compared with uninsured dogs, indicating the value of pet insurance to promote improved healthcare for dogs.

The study confirms that giant breeds, dogs with heavier bodyweights, longer legs or longer skull lengths are all at higher risk of developing osteosarcoma. As body size (giantism) is controlled by genetic factors, these new results can help owners, veterinarians, breeders and researchers to understand the risk factors for this devastating bone cancer and to update their strategies towards choosing to own or breed healthier dogs with lower osteosarcoma risk in the future. Additionally, these findings will help veterinarians to have higher clinical suspicion of typical signs in dogs showing greater risk factors.

Importantly, this new information will also help owners to make more informed choices when deciding on what type of dog to acquire and should encourage us all to prioritise the health of the dog over extreme body shapes. The results can also help researchers to extend the research on osteosarcoma in dogs to improve fundamental and translational bioscience on human osteosarcoma.

Dr Dan O’Neill, Associate Professor in Companion Animal Epidemiology at the RVC, and lead author of the paper, said:

“Given that dogs are recognised as man’s best friend, every dog-owner in return has a responsibility to be a dog’s best friend. We can fulfil this responsibility by ensuring that no pet dog is born into body shape that puts them at substantially increased risk of disease. This new study once again flags the costs that dogs pay for our human drive to own dogs with extreme body shapes that do not occur in nature. By choosing instead to own pet dogs with natural body shapes, we can each do our bit to put the health of the dog above our human whims.”

Dr Grace Edmunds, Clinical Research Fellow, Resident in Internal Medicine at the University of Bristol and co- author of the paper, said:

“Understanding the biological risk factors associated with any disease can help us to work out what causes it. In this case, the risk factors associated with canine osteosarcoma may tell us what causes a dog’s bone cell to become a cancer cell, and how we can kill that cancer once it develops. For those of us who routinely see osteosarcoma in clinical practice, any step towards new treatments for our canine patients is necessary and exciting.

“However, even more thrilling is the idea that, given the similarities between canine and human osteosarcoma, we might be able to use information taken from dogs to help human patients. It is very hard to obtain tissue from human osteosarcoma to work with in the lab and thus we as cancer researchers lack knowledge about the human disease. My hope is that samples from my canine patients can act as the perfect model for me to devise prevention and treatment strategies that can also be translated to humans”.

Bill Lambert, Health, Welfare and Breeding Services Executive at The Kennel Club, added:

“These data importantly help to identify which dogs are most at risk of osteosarcoma and support the growing body of evidence that this disease is sadly more common amongst larger dogs and particular breeds. The findings will be used collaboratively as part of The Kennel Club’s Breed Health and Conservation Plans, to create strategies to tackle health priorities within those breeds that are affected.

“Ultimately this research, funded in part by The Kennel Club’s Charitable Trust as part of our mission to make a difference for dogs, should help owners that may need support in spotting the initial signs and seeking appropriate veterinary care, particularly in those breeds and crossbreeds identified as being at most risk of being affected. Cancer sadly is a common disease of all dogs; statistics suggest around 1 in 3 dogs develop cancer in their lifetime. Causes of cancer are largely unknown, making prevention extremely difficult, but if owners are aware of possible signs of disease, this can help early detection, ensuring appropriate care for recovery.”

Notes to Editors

Reference

O’Neill et al. (2023) “Dog breeds and conformations predisposed to osteosarcoma in the UK: A VetCompass study”. Canine Medicine and Genetics.

The full paper is available online at DOI: 10.1186/s40575-023-00131-2

For media enquiries, please contact:

• Jasmin De Vivo (jasmin.devivo@plmr.co.uk) or rvc@plmr.co.uk
• Press Line: 0800 368 9520

About the RVC

• The Royal Veterinary College (RVC) is the UK's largest and longest established independent veterinary school and is a Member Institution of the University of London.
• It is one of the few veterinary schools in the world that hold accreditations from the RCVS in the UK (with reciprocal recognition from the AVBC for Australasia, the VCI for Ireland and the SAVC for South Africa), the EAEVE in the EU, and the AVMA in the USA and Canada.
• The RVC is ranked as the top veterinary school in the world in the QS World University Rankings by subject, 2023.
• The RVC offers undergraduate and postgraduate programmes in veterinary medicine, veterinary nursing and biological sciences.
• The RVC is a research-led institution, with 88% of its research rated as internationally excellent or world class in the Research Excellence Framework 2021.
• The RVC provides animal owners and the veterinary profession with access to expert veterinary care and advice through its teaching hospitals and first opinion practices in London and Hertfordshire.